NAUT - Nautilus Biotechnology, Inc.

3.48
-0.300   -8.621%

Share volume: 431,935
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$3.78
-0.30
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 35%
Dept financing 21%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.87%
1 Month
50.00%
3 Months
79.38%
6 Months
333.81%
1 Year
292.11%
2 Year
18.37%
Key data
Stock price
$3.48
P/E Ratio 
0.00
DAY RANGE
$3.25 - $3.70
EPS 
-$0.52
52 WEEK RANGE
$0.62 - $4.31
52 WEEK CHANGE
$304.18
MARKET CAP 
91.445 M
YIELD 
N/A
SHARES OUTSTANDING 
126.305 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.44
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$636,375
AVERAGE 30 VOLUME 
$352,841
Company detail
CEO: Sujal M. Patel
Region: US
Website: nautilus.bio
Employees: 130
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.

Recent news